| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/22/2005 | CN1629189A Specific antigen of Japanese blood fluke and its use |
| 06/22/2005 | CN1629188A Specific antigen of Japanese blood fluke and its use |
| 06/22/2005 | CN1629187A Method for direct extraction and purification of algal poison by using alga wet cell |
| 06/22/2005 | CN1629186A Ganoderma lucidum polysaccharide protein and its preparing method and use |
| 06/22/2005 | CN1629185A Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/22/2005 | CN1207387C Polypeptides and genes encoding same |
| 06/22/2005 | CN1207310C Method for preparing galactomannanpeptide and product |
| 06/22/2005 | CN1207306C Peptide compound for preventing and treating HIV infection and immunity diseases |
| 06/22/2005 | CN1207305C Preparing process and application of recombinant human interleukin-11 |
| 06/22/2005 | CN1207302C Method and compounds for curing diseases caused by mutations |
| 06/22/2005 | CA2487107A1 Novel targets for obesity from skeletal muscle |
| 06/22/2005 | CA2451549A1 The sesl vaccine |
| 06/21/2005 | US6909032 DNA encoding a macadamia integrifolia anti-microbial protein, constructs comprising the same and plant material comprising the constructs |
| 06/21/2005 | US6909031 Expression vector coding protein for use in the treatment of diabetes |
| 06/21/2005 | US6909030 PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes |
| 06/21/2005 | US6908993 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents |
| 06/21/2005 | US6908990 Insulin promoter factor, and uses related thereto |
| 06/21/2005 | US6908988 Animal models; medical diagnosis; antitumor agents |
| 06/21/2005 | US6908987 Comprises nucleotide sequences coding peroxisome proliferator activator receptor protein (PCG) for modulating thermogenesis in adipocytes and treating obesity |
| 06/21/2005 | US6908986 Nucleotide sequences coding polypeptide for use in the treatment of rheumatoid arthritis, autoimmune, allergies, inflammation, infections, leukemia, tumors, fibrosis, psoriasis and sepsis |
| 06/21/2005 | US6908985 Heat-shock protein- binding proteins; useful in the regulation of physiological events in which one or more 70 kiloDalton heat-shock proteins (Hsp70) are involved, such as normal development, cellular stress responses, heart disease |
| 06/21/2005 | US6908963 Coupling a polypeptide to end grouped modified polyether m |
| 06/21/2005 | US6908899 Pro-inflammatory fibrinopeptide |
| 06/21/2005 | US6908898 Angiogenesis related molecules |
| 06/21/2005 | US6908897 At least one is a human or animal insulin analogue; coupled together with a diacid such as by reacting with suberic acid, bis(N-hydroxysuccinimidyl) ester |
| 06/21/2005 | US6908765 Polypeptide—human SR splicing factor 52 and a polynucleotide encoding the same |
| 06/21/2005 | US6908761 Transcriptional activators |
| 06/21/2005 | US6908755 Comprise enzymatic polypepdide for diagnosis, prevention and treatment of tumors; antiproliferative agents |
| 06/21/2005 | US6908750 Gene encoding HM1.24 antigen protein and promoter thereof |
| 06/21/2005 | US6908749 Generation of preferential human serum albumins; obtain serum albumin broth, heat, filter, remove impurities, recover serum albumin |
| 06/21/2005 | US6908748 The protein encoded by novel gene has two WW domains that participate in protein interactions in the N-terminal domain, and this protein binds to other proteins, thus regulates the intracellular signal transduction, gene expression |
| 06/21/2005 | US6908747 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 06/21/2005 | US6908744 Comprises disruption in ophan receptor ROR2 gene in chondrocytes cells; drug screening; treating osteoarthritis |
| 06/21/2005 | US6908734 Sulfated CCR5 peptides for HIV-1 infection |
| 06/21/2005 | US6908619 Isolated nucleic acid molecule consisting of sequence encoding immunogenic polypeptide having at least 90% sequence identity to specified contiguous amino acid sequence |
| 06/21/2005 | US6908618 Production of novel bovine respiratory syncytial viruses from cDNAs |
| 06/21/2005 | US6908616 Composition suitable for immunizing crustaceans by injection against White Spot Syndrome Virus, WSSV, comprising isolated protein consisting of specified amino acid sequence, which delays mortality against WSSV infectivity in crustaceans |
| 06/21/2005 | US6908615 DNA encoding human papilloma virus type 18 |
| 06/21/2005 | US6908613 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/21/2005 | US6908612 Virus coat protein/receptor chimeras and methods of use |
| 06/21/2005 | US6908605 Non-invasive localization of a light-emitting conjugate in a mammal |
| 06/21/2005 | US6907887 Genetically engineered plants having reduced nitrosonornicotine, N'-nitrosoanatabine, N'- nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-(3-pyridyl)- 1-butanone levels; cured tobacco |
| 06/21/2005 | CA2343721C Maize promoters |
| 06/21/2005 | CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 06/21/2005 | CA2145749C Thrombin activatable plasminogen derivatives |
| 06/21/2005 | CA2145005C Monoclonal antibodies specific for tcf-ii |
| 06/21/2005 | CA2118498C A novel anti-neoplastic cytokine |
| 06/21/2005 | CA2049679C Hepatitis c assay utilizing recombinant antigens |
| 06/21/2005 | CA2044421C Squamous cell carcinoma-like immunoreactive antigen from human female urine |
| 06/21/2005 | CA2015677C Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines |
| 06/18/2005 | CA2450000A1 Method of creating plants with reduced level of saturated fatty acid in seed oil |
| 06/16/2005 | WO2005054509A2 Assay and treatment |
| 06/16/2005 | WO2005054485A2 Adenovirus-transfected primary cells and methods of pathway mapping |
| 06/16/2005 | WO2005054484A1 Promoters for expression in modified vaccinia virus ankara |
| 06/16/2005 | WO2005054472A1 Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same |
| 06/16/2005 | WO2005054471A1 Novel centromeric protein shugoshin |
| 06/16/2005 | WO2005054468A1 Target protein of antidiabetic agent and novel antidiabetic agent “insuful” corresponding thereto |
| 06/16/2005 | WO2005054467A1 EXPRESSION SYSTEM WITH THE USE OF MAMMALIAN β-ACTIN PROMOTER |
| 06/16/2005 | WO2005054465A1 Method of obtaining gene tag |
| 06/16/2005 | WO2005054464A1 Fluorescent proteins |
| 06/16/2005 | WO2005054460A1 Crystal of oxidized ldl-recognition domain of oxidized ldl receptor lox-1, stereostructure thereof and utilization of the same |
| 06/16/2005 | WO2005054449A1 Use of il-6-type cytokines for maturation of oocytes |
| 06/16/2005 | WO2005054445A1 A method for isolating a self-renewing, multipotent slow-cycling cell |
| 06/16/2005 | WO2005054433A2 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 06/16/2005 | WO2005054426A2 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
| 06/16/2005 | WO2005054293A1 Rgd targeting moiety its porduction and use |
| 06/16/2005 | WO2005054292A1 Compositions and methods related to a dimeric mhc class i and ii-like molecule (dsmhc i and dsmhc ii) |
| 06/16/2005 | WO2005054291A1 Single-chain insulin |
| 06/16/2005 | WO2005054290A2 Peptide hormones zalpha48 and zsig97 |
| 06/16/2005 | WO2005054289A1 Process for purifying interferon beta |
| 06/16/2005 | WO2005054288A1 Process for purifying interferon beta |
| 06/16/2005 | WO2005054287A1 Process for producing human interferon alpha |
| 06/16/2005 | WO2005054286A2 Interleukin-11 fusion proteins |
| 06/16/2005 | WO2005054285A1 Gag binding proteins |
| 06/16/2005 | WO2005054284A2 Regulation involving abin-2 |
| 06/16/2005 | WO2005054283A2 Clp-protease as target for herbicides |
| 06/16/2005 | WO2005054282A1 Protein nmb0928 and use thereof in pharmaceutical formulations |
| 06/16/2005 | WO2005054281A2 Protein nmb1125 and use thereof in pharmaceutical formulations |
| 06/16/2005 | WO2005054280A2 Methods of producing disease-resistant animals |
| 06/16/2005 | WO2005054275A2 Nanofiltration of factor vii solutions to remove virus |
| 06/16/2005 | WO2005053811A2 Biomolecule partition motifs and uses thereof |
| 06/16/2005 | WO2005053751A1 Animal model for experimental allergic neuritis and uses thereof |
| 06/16/2005 | WO2005053729A1 Stem cell factor for inducing neural stem cell migration to areas of neurological injury |
| 06/16/2005 | WO2005053726A1 Selective neuropeptide y2 receptor agonists |
| 06/16/2005 | WO2005053618A2 Synthetic hla binding peptide analogues and uses thereof |
| 06/16/2005 | WO2005053603A2 Antigen receptor variable region typing |
| 06/16/2005 | WO2005053516A2 Replication competent hepatitis c virus and methods of use |
| 06/16/2005 | WO2005053505A2 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 06/16/2005 | WO2005053396A1 Means for the transport and storage of cells or living tissues |
| 06/16/2005 | WO2005053387A1 Non-human mammalian and non-mammalian animal models of age-related memory impairment |
| 06/16/2005 | WO2005040333A3 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 06/16/2005 | WO2005033144A3 Tim-3 polypeptides |
| 06/16/2005 | WO2005026370A3 Multi-antigen vectors for melanoma |
| 06/16/2005 | WO2005026211A3 Anti-ghrelin antibodies |
| 06/16/2005 | WO2005024032A3 Targeting adenoviral vectors to dendritic cells |
| 06/16/2005 | WO2005023862A3 Homogeneous preparations of il-28 and il-29 |
| 06/16/2005 | WO2005023861A3 Gdnf-related neuropeptides |
| 06/16/2005 | WO2005021585A3 Axmi-003, a delta-endotoxin gene and methods for its use |
| 06/16/2005 | WO2005018650A3 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 06/16/2005 | WO2005014645A3 Pedf-r receptor and uses |